Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice

Author： Czuczwar S.J. Borowicz K.K. Kleinrok Z. Tutka P. Zarnowski T. Turski W.A.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.281, Iss.3, 1995-08, pp. : 327-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice

By Tutka P. Olszewski K. Wozniak M. Kleinrok Z. Czuczwar S.J. Wielosz M.

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 321-326

Elsevier

Access to resources Recommend Favorite

Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine

By Sukhotina I. Dravolina O. Bespalov A.

European Journal of Pharmacology, Vol. 362, Iss. 2, 1998-12 ,pp. : 103-110

Elsevier

Access to resources Recommend Favorite

Competitive Gly/NMDA Receptor Antagonists

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 809-821

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists

By Vasiliadis H.-M. Elie R. Dewar K.M.

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A. Popik P. Bespalov A.Y. Danysz W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite